"You decide and we provide."
Cart 0

Roche's Tecentriq wins FDA approval for treating advanced bladder cancer

reutersCOMPANYNEWS companyNews

April 17 (Reuters) - Genentech, a unit of Swiss drugmaker Roche Holding AG, said on Monday it got approval from the U.S. Food and Drug Administration for its already approved immunotherapy drug, Tecentriq, to treat advanced bladder cancer.

Older Post Newer Post

Leave a comment

Please note, comments must be approved before they are published